PS PeptideSuppliers.org Finding the right peptide supplier for you
Ipamorelin reference image
View supplier listing 15% off with code KING15
Peptide guide

Ipamorelin Peptide Guide & Supplier Listing Notes

Ghrelin receptor/GH secretagogue peptide

Ghrelin receptor / GH secretagogue research

Growth hormone secretagogue research compounds Educational guide Supplier transparency
Back to directory Compare supplier pages

Research Areas

The main research domains where this compound appears most often.

The main research area for ipamorelin is growth hormone release. Pharmacology studies focus on receptor activation, endocrine response, and selectivity.

Another research area is gastrointestinal function. Some preclinical work has evaluated ipamorelin and related ghrelin mimetics in models of postoperative ileus or gut motility. This adds a useful dimension beyond bodybuilding-style discussions.

Ipamorelin is also important for comparison pages. Readers often compare ipamorelin with sermorelin, CJC-1295, GHRP-2, and GHRP-6. receptor differences and avoid treating all GH-axis peptides as interchangeable.

Animal studies

What preclinical work has emphasized

Preclinical studies have helped define ipamorelin's receptor activity, endocrine selectivity, and potential effects in gastrointestinal models. Rodent research has investigated whether ipamorelin can influence gut motility and recovery after intestinal manipulation.

Animal studies are valuable for mechanism, but they do not establish broad human outcomes. They should be used to explain why ipamorelin is scientifically interesting while keeping claims limited to what the models can support.

Human studies

How much human evidence exists

Human research on ipamorelin is more limited than the public discussion often suggests. Much of the strongest literature comes from pharmacology and preclinical studies. The human section should therefore be cautious and transparent.

A balanced summary is that ipamorelin has a clear mechanistic identity as a selective GH secretagogue, but human clinical evidence is not as extensive as it is for some approved endocrine compounds such as tesamorelin.

Current research status

Where the research stands now

Ipamorelin remains a commonly discussed GH secretagogue in peptide education. Its main research value is comparative: it helps explain ghrelin receptor-mediated GH release and how that differs from GHRH receptor-mediated GH release.

Current interest focuses on receptor selectivity, GH-axis signaling, and the broader biology of ghrelin receptor agonists.

Browse suppliers Open peptide directory Read education guides Best peptide suppliers

Related Compounds

Closely related compounds frequently discussed within the same research category.

GHRP-2 and GHRP-6 are related because they are earlier growth hormone-releasing peptides. Sermorelin, CJC-1295, and tesamorelin are related because they also influence GH release but through GHRH signaling. Growth hormone is biologically downstream but not the same type of compound.

CJC-1295 Sermorelin Hexarelin Tesamorelin
Supplier considerations

How to read supplier pages more carefully

Ipamorelin listings should clearly distinguish it from GHRP-2, GHRP-6, and CJC-1295 blends. Researchers should look for COAs, identity confirmation, purity reporting, batch numbers, and storage instructions. Because ipamorelin is commonly marketed with broad performance claims, documentation should matter more than promotional language.

  • Look for batch-specific COAs instead of generic laboratory files reused across many listings.
  • Check whether the product name, concentration language, and batch references stay consistent from page to page.
  • Read storage and handling notes alongside the document links rather than treating the headline purity claim as enough.
  • Prefer supplier pages that keep research-use labeling, contact details, and policy pages easy to verify.

Linked supplier pages

Supplier pages that help compare naming, documentation access, batch references, and overall page clarity.

Supplier listing

Peptides Kingdom

This listing helps with checking naming, documentation access, storage language, and overall page clarity.

View supplier listing
15% off with code KING15

Frequently Asked Questions

Common questions drawn from the published literature and documentation context.

What is ipamorelin?

Ipamorelin is a synthetic growth hormone secretagogue studied for stimulating GH release through the ghrelin receptor.

Is ipamorelin a GHRH analog?

No. It acts through the growth hormone secretagogue receptor, not the GHRH receptor.

How is ipamorelin different from sermorelin?

Sermorelin activates GHRH receptors; ipamorelin activates ghrelin receptors.

What is ipamorelin studied for?

It is studied for GH release, endocrine selectivity, receptor pharmacology, and some gastrointestinal models.

Does ipamorelin have human research?

Human research is more limited than preclinical and pharmacology literature.

What compounds are related to ipamorelin?

GHRP-2, GHRP-6, sermorelin, CJC-1295, and tesamorelin are commonly related.

Why is ipamorelin called selective?

Early research described it as selectively stimulating GH release compared with some older secretagogues.

What should researchers check when comparing suppliers?

COAs, purity, lot number, identity testing, and storage guidance.

References

Primary sources and clinical references cited in this overview.